Immuneering | 4.93 +0.41 +9.07% | ||
| IMRX | |||
| 高 5.02 | 开 4.62 | 量 157.68万股 | 总市值 3.18亿 |
| 低 4.60 | 换 2.44% | 额 770.12万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
Immuneering(IMRX)
02-05 21:55
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000034 Size: 5 KB 网页链接
Immuneering(IMRX)
02-05 21:45
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000032 Size: 5 KB 网页链接
Immuneering(IMRX)
02-05 21:35
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000028 Size: 5 KB 网页链接
Immuneering(IMRX)
02-05 21:35
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000030 Size: 5 KB 网页链接
Immuneering(IMRX)
02-05 21:25
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000024 Size: 5 KB 网页链接
Immuneering(IMRX)
02-05 21:25
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000026 Size: 5 KB 网页链接
Immuneering(IMRX)
02-05 21:15
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000022 Size: 5 KB 网页链接
Immuneering(IMRX)
01-22 22:05
$Immuneering(IMRX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001790340-26-000020 Act: 34 Size: 7 KB 网页链接
Immuneering(IMRX)
01-21 22:15
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000016 Size: 4 KB 网页链接
Immuneering(IMRX)
01-20 22:25
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000014 Size: 4 KB 网页链接
Immuneering(IMRX)
01-17 05:15
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000012 Size: 4 KB 网页链接
Immuneering(IMRX)
01-16 02:25
$Immuneering(IMRX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-26-000247 Act: 34 Size: 12 KB 网页链接
Immuneering(IMRX)
01-15 21:15
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000010 Size: 4 KB 网页链接
Immuneering(IMRX)
01-14 21:15
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000008 Size: 7 KB 网页链接
Immuneering(IMRX)
01-08 05:15
$Immuneering(IMRX)$ 8-K Current report, item 8.01 Accession Number: 0001790340-26-000006 Act: 34 Size: 153 KB 网页链接
Immuneering(IMRX)
01-03 06:05
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000004 Size: 5 KB 网页链接
Immuneering(IMRX)
01-03 05:55
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-26-000002 Size: 5 KB 网页链接
Immuneering(IMRX)
2025-11-13 05:25
$Immuneering(IMRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001790340-25-000135 Act: 34 Size: 6 MB 网页链接
Immuneering(IMRX)
2025-11-13 05:15
$Immuneering(IMRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001790340-25-000133 Act: 34 Size: 272 KB 网页链接
Immuneering(IMRX)
2025-10-21 21:05
$Immuneering(IMRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-25-004478 Act: 34 Size: 17 KB 网页链接